SERA PROGNOSTICS, INC. Increase (Decrease) in Accounts Payable
SERA PROGNOSTICS, INC. (SERA) reported Increase (Decrease) in Accounts Payable of $741.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-08-12
- SERA PROGNOSTICS, INC. increase (decrease) in accounts payable for the quarter ending 2026-06-30 was $811.00K, a 2696.55% increase year-over-year.
- SERA PROGNOSTICS, INC. increase (decrease) in accounts payable for the quarter ending 2026-03-31 was -$70.00K.
- SERA PROGNOSTICS, INC. increase (decrease) in accounts payable for the quarter ending 2025-12-31 was -$94.00K, a 124.61% decline year-over-year.
- SERA PROGNOSTICS, INC. increase (decrease) in accounts payable for the quarter ending 2025-09-30 was $52.00K, a 54.78% decline year-over-year.
- SERA PROGNOSTICS, INC. increase (decrease) in accounts payable for fiscal 2025 was -$1.01M, a 321.76% decline from fiscal 2024.
- SERA PROGNOSTICS, INC. increase (decrease) in accounts payable for fiscal 2024 was $455.00K.
- SERA PROGNOSTICS, INC. increase (decrease) in accounts payable for fiscal 2023 was -$442.00K, a 225.57% decline from fiscal 2022.
- SERA PROGNOSTICS, INC. increase (decrease) in accounts payable for fiscal 2022 was $352.00K, a 41.63% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|
| 2026-06-30 | $811.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $741.00K 10-Q · filed 2026-08-12 | $647.00K derived: sum of 3 quarters · filed 2026-08-12 | $699.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | -$70.00K 10-Q · filed 2026-05-06 | -$164.00K derived: sum of 2 quarters · filed 2026-05-06 | -$112.00K derived: sum of 3 quarters · filed 2026-05-06 | -$83.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | -$94.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | -$42.00K derived: sum of 2 quarters · filed 2026-03-18 | -$13.00K derived: sum of 3 quarters · filed 2026-08-12 | -$1.01M 10-K · filed 2026-03-18 |
| 2025-09-30 | $52.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $81.00K derived: sum of 2 quarters · filed 2026-08-12 | -$915.00K 10-Q · filed 2025-11-13 | -$533.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | $29.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$967.00K 10-Q · filed 2026-08-12 | -$585.00K derived: sum of 3 quarters · filed 2026-08-12 | -$470.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | -$996.00K 10-Q · filed 2026-05-06 | -$614.00K derived: sum of 2 quarters · filed 2026-05-06 | -$499.00K derived: sum of 3 quarters · filed 2026-05-06 | -$514.00K derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $382.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $497.00K derived: sum of 2 quarters · filed 2026-03-18 | $482.00K derived: sum of 3 quarters · filed 2026-03-18 | $455.00K 10-K · filed 2026-03-18 |
| 2024-09-30 | $115.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $100.00K derived: sum of 2 quarters · filed 2025-11-13 | $73.00K 10-Q · filed 2025-11-13 | -$107.00K derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | -$15.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | -$42.00K 10-Q · filed 2025-08-06 | -$222.00K derived: sum of 3 quarters · filed 2025-08-06 | -$195.00K derived: sum of 4 quarters · filed 2025-08-06 |
| 2024-03-31 | -$27.00K 10-Q · filed 2025-05-07 | -$207.00K derived: sum of 2 quarters · filed 2025-05-07 | -$180.00K derived: sum of 3 quarters · filed 2025-05-07 | -$464.00K derived: sum of 4 quarters · filed 2025-05-07 |
| 2023-12-31 | -$180.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-19 | -$153.00K derived: sum of 2 quarters · filed 2025-03-19 | -$437.00K derived: sum of 3 quarters · filed 2025-03-19 | -$442.00K 10-K · filed 2025-03-19 |
| 2023-09-30 | $27.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | -$257.00K derived: sum of 2 quarters · filed 2024-11-06 | -$262.00K 10-Q · filed 2024-11-06 | $294.00K derived: sum of 4 quarters · filed 2024-11-06 |
| 2023-06-30 | -$284.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | -$289.00K 10-Q · filed 2024-08-07 | $267.00K derived: sum of 3 quarters · filed 2024-08-07 | $547.00K derived: sum of 4 quarters · filed 2024-08-07 |
| 2023-03-31 | -$5.00K 10-Q · filed 2024-05-08 | $551.00K derived: sum of 2 quarters · filed 2024-05-08 | $831.00K derived: sum of 3 quarters · filed 2024-05-08 | $599.00K derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | $556.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-20 | $836.00K derived: sum of 2 quarters · filed 2024-03-20 | $604.00K derived: sum of 3 quarters · filed 2024-03-20 | $352.00K 10-K · filed 2024-03-20 |
| 2022-09-30 | $280.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $48.00K derived: sum of 2 quarters · filed 2023-11-08 | -$204.00K 10-Q · filed 2023-11-08 | -$119.00K derived: sum of 4 quarters · filed 2023-11-08 |
| 2022-06-30 | -$232.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$484.00K 10-Q · filed 2023-08-09 | -$399.00K derived: sum of 3 quarters · filed 2023-08-09 | -$78.00K derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | -$252.00K 10-Q · filed 2023-05-10 | -$167.00K derived: sum of 2 quarters · filed 2023-05-10 | $154.00K derived: sum of 3 quarters · filed 2023-05-10 | $12.00K derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | $85.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | $406.00K derived: sum of 2 quarters · filed 2023-03-22 | $264.00K derived: sum of 3 quarters · filed 2023-03-22 | $603.00K 10-K · filed 2023-03-22 |
| 2021-09-30 | $321.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $179.00K derived: sum of 2 quarters · filed 2022-11-09 | $518.00K 10-Q · filed 2022-11-09 | $377.00K derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | -$142.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | $197.00K 10-Q · filed 2022-08-10 | $56.00K derived: sum of 3 quarters · filed 2022-08-10 | $172.00K derived: sum of 4 quarters · filed 2022-08-10 |
| 2021-03-31 | $339.00K 10-Q · filed 2022-05-10 | $198.00K derived: sum of 2 quarters · filed 2022-05-10 | $314.00K derived: sum of 3 quarters · filed 2022-05-10 | |
| 2020-12-31 | -$141.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | -$25.00K derived: sum of 2 quarters · filed 2022-03-29 | -$307.00K 10-K · filed 2022-03-29 | |
| 2020-09-30 | $116.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | -$166.00K 10-Q · filed 2021-11-09 | ||
| 2020-06-30 | -$282.00K 10-Q · filed 2021-08-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |